Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MK-2118 |
| Trade Name | |
| Synonyms | MK2118|MK 2118 |
| Drug Descriptions |
MK-2118 is a STING agonist that may activate innate anti-tumor immune response (PMID: 33618600). |
| DrugClasses | STING1 Agonist 21 |
| CAS Registry Number | NA |
| NCIT ID | C176562 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| MK-2118 | MK-2118 | 0 | 1 |
| MK-2118 + Pembrolizumab | MK-2118 Pembrolizumab | 0 | 1 |